Latest News for POCI
Precision Optics (NASDAQ: POCI) reported record revenue in its fiscal second quarter ended Dec. 31, 2025, as strong demand in two large production programs continued to build, though the company said manufacturing inefficiencies and yield issues weighed heavily on margins and profitability. Record quarterly revenue driven by production programs CEO Dr. Joe Forkey said second-quarter revenue
Precision Optics Corporation, Inc. (POCI) Q2 2026 Earnings Call Transcript
GARDNER, Mass., Feb. 13, 2026 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (Nasdaq: POCI) (the "Company"), a leading designer and manufacturer of advanced optical instruments for the medical and defense/aerospace industries, today announced that it has scheduled a conference call to discuss the Company's second quarter fiscal year 2026 financial results on Tuesday, February 17, 2026, at 5:00 p.m. ET.
Precision Optics (NASDAQ: POCI - Get Free Report) and Imris (OTCMKTS:IMRSQ - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, earnings, risk, institutional ownership and valuation. Institutional and Insider Ownership 13.7% of Precision Optics shares
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for POCI.
U.S. House Trading
No House trades found for POCI.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.